We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Top Sells

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$62.3M
2
MLCO icon
Melco Resorts & Entertainment
MLCO
+$50M
3
WBA
Walgreens Boots Alliance
WBA
+$31.8M
4
MANH icon
Manhattan Associates
MANH
+$27.4M
5
CPA icon
Copa Holdings
CPA
+$25.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORLY icon
201
O'Reilly Automotive
ORLY
$72.4B
$1.75M 0.03%
174,975
+1,500
+0.9% +$15.3K
MDVN
202
DELISTED
MEDIVATION, INC.
MDVN
$1.74M 0.03%
+35,166
New +$1.49M
CPRI icon
203
Capri Holdings
CPRI
$1.77B
$1.73M 0.03%
24,169
-1,203
-5% -$96.7K
BMY icon
204
Bristol-Myers Squibb
BMY
$127B
$1.72M 0.03%
33,588
+957
+3% +$47.8K
ANSS
205
DELISTED
Ansys
ANSS
$1.71M 0.03%
22,595
+13,195
+140% +$1.03M
ROP icon
206
Roper Technologies
ROP
$36.3B
$1.69M 0.03%
11,540
-585
-5% -$86K
ALXN
207
DELISTED
Alexion Pharmaceuticals
ALXN
$1.69M 0.03%
10,165
-56
-0.5% -$9.2K
THS
208
DELISTED
Treehouse Foods
THS
$1.67M 0.03%
20,680
-800
-4% -$63.2K
MBLY
209
DELISTED
Mobileye N.V.
MBLY
$1.65M 0.03%
+30,855
New +$1.35M
RGA icon
210
Reinsurance Group of America
RGA
$15.7B
$1.65M 0.03%
20,585
-1,002
-5% -$81.6K
FCX icon
211
Freeport-McMoran
FCX
$90B
$1.62M 0.03%
49,653
+2,745
+6% +$99.7K
PTR
212
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$1.61M 0.03%
12,565
– –
EOG icon
213
EOG Resources
EOG
$78B
$1.61M 0.03%
16,301
-208,180
-93% -$22.6M
CMCSK
214
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$1.6M 0.03%
29,907
+2,360
+9% +$126K
IVV icon
215
iShares Core S&P 500 ETF
IVV
$876B
$1.59M 0.03%
8,042
+425
+6% +$84.6K
FNGN
216
DELISTED
Financial Engines, Inc.
FNGN
$1.58M 0.03%
46,176
-543,896
-92% -$20M
WMT icon
217
Walmart Inc
WMT
$871B
$1.57M 0.03%
61,647
-5,070
-8% -$128K
IBN icon
218
ICICI Bank
IBN
$106B
$1.57M 0.03%
175,412
+36,119
+26% +$338K
VNQ icon
219
Vanguard Real Estate ETF
VNQ
$39.9B
$1.56M 0.03%
21,784
-1,447
-6% -$109K
VNRBP
220
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
$1.56M 0.03%
63,250
+12,500
+25% +$311K
LVS icon
221
Las Vegas Sands
LVS
$30.5B
$1.56M 0.03%
25,098
-7,860
-24% -$540K
CL icon
222
Colgate-Palmolive
CL
$72.6B
$1.55M 0.03%
23,847
+1,936
+9% +$128K
NSC icon
223
Norfolk Southern
NSC
$78.8B
$1.54M 0.03%
13,819
– –
YUM icon
224
Yum! Brands
YUM
$41B
$1.54M 0.03%
29,710
+424
+1% +$22.6K
BMRN icon
225
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.54M 0.03%
21,287
+1,255
+6% +$82.5K
7 8
9
10 11

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.